Nipah Virus Under the Microscope | Chenghui Medical’s Comprehensive Molecular Detection Solution to Strengthen Prevention and Control
Recently, an outbreak of the Nipah virus occurred in the state of West Bengal, India, with five confirmed cases and nearly one hundred people placed under home isolation. Neighboring countries have simultaneously tightened health screening measures at their borders, drawing widespread attention within the global public health community.
The virus carries a fatality rate of 40–75% and currently lacks specific vaccines or treatments; consequently, rapid and accurate detection has become a critical element in its prevention and control. In response to this urgent need, Chenghui Medical has acted swiftly to deploy a comprehensive nucleic acid detection solution for the Nipah virus, providing robust professional technical support for outbreak control efforts.
Fully Premixed Lyophilized Kits: A New Experience in Rapid and Efficient Diagnostics
Chenghui Medical’s Nipah Virus Nucleic Acid Detection Kit (Fluorescent PCR with Probe Method) utilizes fully premixed lyophilization technology, enabling a revolutionary simplification of the workflow. It significantly reduces human error and operational time, making it ideal for screening scenarios such as border crossings, disease control centers, and entry/exit checkpoints.
Simple and Easy to Use: Fully premixed—no reagent preparation required; simply add the sample for immediate use.
Room-Temperature Storage and Transport: Lyophilized reagents, suitable for logistics without a cold chain and for emergency deployment.
Accurate and Reliable: Based on the gold standard of fluorescence PCR, featuring internal controls throughout the entire process for accurate virus detection.
Fast and Efficient: Compatible with major fluorescence PCR systems, with results available in just 60 minutes.
Automated Nucleic Acid Analyzer: Creating a Closed-Loop System for Rapid, On-Site Diagnostics
Chenghui Medical’s Automated Nucleic Acid Analyzer (CH-0104) integrates nucleic acid extraction and quantitative fluorescence PCR using centrifugal microfluidic technology, enabling the fully automated detection of up to 16 pathogens in just 30 minutes. Featuring a “sample in, result out” workflow, it is designed to meet the demands for rapid screening at border crossings, emergency scenarios, and other on-site settings.
Rapid Emergency Response: Simultaneous detection of up to 16 pathogens in just 30 minutes, providing effective support for public health emergencies and infection traceability.
Completely Contamination-Free Process: A fully enclosed cartridge design prevents cross-contamination and aerosol generation, ensuring safe and reliable operation.
Barrier-Free Operation: A single-step sample loading process featuring full automation—ideal for rapid, on-site testing.
On-Demand Analysis: 1–8 channels with flexible expansion capabilities, supporting the simultaneous detection of multiple targets.
Public health leaves no room for oversight; emergency response reflects both responsibility and commitment. Chenghui Medical remains firmly focused on technological innovation, delving deeper into the field of molecular diagnostics and bolstering public health security with reliable products and solutions.
Looking ahead, we will continue to drive development to deliver more efficient and accessible solutions for all types of public health emergencies, thereby contributing to the strengthening of our collective health defenses.
